In vitro system to evaluate oral absorption of poorly water-soluble drugs: simultaneous analysis on dissolution and permeation of drugs
- PMID: 14620525
- DOI: 10.1023/a:1026107906191
In vitro system to evaluate oral absorption of poorly water-soluble drugs: simultaneous analysis on dissolution and permeation of drugs
Abstract
Purpose: The aim of the present work was to develop a new in vitro system to evaluate oral absorption of poorly water-soluble drugs by utilizing Caco-2 monolayers.
Methods: Caco-2 monolayer was mounted between side-by-side chambers, which enabled the simultaneous assay of dissolution and permeation of drugs (dissolution/permeation system; D/P system). Apical and basal sides of the chamber were filled with buffer solutions. Drugs were applied to the apical side as powder, suspension, or solution, and then, the permeated amounts into the basal side were monitored for 2 h. At the same time, dissolved amounts of drugs at the apical side were detected. The amount of drug applied to the D/P system was based on its in vivo clinical dose.
Results: Sodium taurocholate (5 mM, apical side) and bovine serum albumin (4.5% w/v, basal side) increased the permeated amount of poorly water-soluble drugs. Both additives were considered to be effective at mimicking in vivo conditions of intestinal drug absorption. From the correlation between the permeated amount of 13 drugs (% dose/2 h) in the D/P system and their percentage dose absorbed in humans in vivo, this system was found to be useful in evaluating oral absorption of poorly water-soluble drugs.
Conclusions: With attempts made to mimic the physiologic conditions of the human GI tract, in vivo oral absorption of drugs was quantitatively assessed in the D/P system in vitro. This system is quite useful to predict the oral absorption of poorly water-soluble drugs after administration as solid dosage forms.
Similar articles
-
Effects of gastric pH on oral drug absorption: In vitro assessment using a dissolution/permeation system reflecting the gastric dissolution process.Eur J Pharm Biopharm. 2016 Apr;101:103-11. doi: 10.1016/j.ejpb.2016.02.002. Epub 2016 Feb 9. Eur J Pharm Biopharm. 2016. PMID: 26873006
-
Advantage of the Dissolution/Permeation System for Estimating Oral Absorption of Drug Candidates in the Drug Discovery Stage.Mol Pharm. 2016 May 2;13(5):1564-74. doi: 10.1021/acs.molpharmaceut.6b00044. Epub 2016 Apr 13. Mol Pharm. 2016. PMID: 27031624
-
An in vitro system for prediction of oral absorption of relatively water-soluble drugs and ester prodrugs.Int J Pharm. 2003 Sep 16;263(1-2):35-44. doi: 10.1016/s0378-5173(03)00343-0. Int J Pharm. 2003. PMID: 12954178
-
Prediction of human pharmacokinetics--gastrointestinal absorption.J Pharm Pharmacol. 2007 Jul;59(7):905-16. doi: 10.1211/jpp.59.7.0001. J Pharm Pharmacol. 2007. PMID: 17637184 Review.
-
Integrating drug permeability with dissolution profile to develop IVIVC.Biopharm Drug Dispos. 2012 Oct;33(7):354-65. doi: 10.1002/bdd.1792. Epub 2012 Jun 7. Biopharm Drug Dispos. 2012. PMID: 22581486 Review.
Cited by
-
Development of an in vitro rat intestine segmental perfusion model to investigate permeability and predict oral fraction absorbed.Pharm Res. 2006 Jul;23(7):1543-53. doi: 10.1007/s11095-006-0249-y. Epub 2006 Jun 21. Pharm Res. 2006. PMID: 16779709
-
Nanoseeded Desupersaturation and Dissolution Tests for Elucidating Supersaturation Maintenance in Amorphous Solid Dispersions.Pharmaceutics. 2023 Jan 30;15(2):450. doi: 10.3390/pharmaceutics15020450. Pharmaceutics. 2023. PMID: 36839772 Free PMC article.
-
The Biopharmaceutics Classification System: subclasses for in vivo predictive dissolution (IPD) methodology and IVIVC.Eur J Pharm Sci. 2014 Jun 16;57:152-63. doi: 10.1016/j.ejps.2014.01.009. Epub 2014 Jan 28. Eur J Pharm Sci. 2014. PMID: 24486482 Free PMC article.
-
Rate-limiting steps of oral absorption for poorly water-soluble drugs in dogs; prediction from a miniscale dissolution test and a physiologically-based computer simulation.Pharm Res. 2008 Oct;25(10):2334-44. doi: 10.1007/s11095-008-9637-9. Epub 2008 Jun 17. Pharm Res. 2008. PMID: 18560998
-
The Need for Restructuring the Disordered Science of Amorphous Drug Formulations.Pharm Res. 2017 Sep;34(9):1754-1772. doi: 10.1007/s11095-017-2174-7. Epub 2017 May 18. Pharm Res. 2017. PMID: 28523384 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical